While the standard of care for muscle invasive bladder cancer is to remove the entire bladder, in some 30 percent of patients, these organs do not harbor residual cancer, especially after chemotherapy treatment. Today, there is no reliable way to identif...
Read More
Fox Chase Cancer Center’s Robert G. Uzzo, MD, FACS, received the 2018 SUO Medal from the Society of Urologic Oncology (SUO) for his significant contributions to the field of urologic oncology. This prestigious award is presented to one member of SUO annuall...
Read More
When your patients are referred to Fox Chase Cancer Center’s Urologic Oncology department, chances are that the first person they will talk with will be Tina Larason. She is the office’s lynchpin, a 15-year Fox Chase veteran who is dedicated to making patie...
Read More
Two Fox Chase Cancer Center urologic oncologists participated in presentations at the spring 2018 annual meeting of the American Urological Association (AUA) and the Society for Urologic Oncology (SUO).Rosalia Viterbo, MD, FACS, brought her extensive experi...
Read More
When it comes to keeping cancer at bay, there’s both good news and bad.The bad news is that there’s no foolproof way to prevent it. As for the good? Everyone can take steps to significantly lower their risk. “Cancer can be genetic or sporadic,” said Sanjay ...
Read More
By harnessing the patient’s own immune system to counterattack lung cancer cells, immunotherapy medications are a revolutionary new approach to treating this disease. Lung cancer is the second most common cancer in the U.S. and by far the leading cause of d...
Read More
